Besides metabolic disorders, Gremlin-1 has been found to be increased in chronic fibrotic diseases of the heart following myocardial ischemia [5], the kidney [6] and lung [7], and involved in initiation and progression of various types of cancer [8]. Here, GREM1 is linked to metabolic disease.